retatrutide phase 2 trial weight loss results retatrutide clinical trial results Retatrutide: A Triple Agonist Shaping the Future of Metabolic Care retatrutide weight loss phase 2

Diabetes indications and obesity indications are often treated differently by insurance plans

Vial Duration At 10 units/injection, 5x/week (loading phase): 50 units per week 200 units per vial (2mL = 200 units on U-100 syringe) One vial lasts 4 weeks At 5 units/injection, 3x/week (maintenance half the loading dose): 15 units per week One vial lasts ~13 weeks Affiliate disclosure: vendor links in this article are affiliate links The Peptide Catalog may earn a commission if you buy through them, at no additional cost to you

The compound is supplied as a lyophilized powder in a sealed glass vial, 10 mg per vial

Excessive consumption can cause discomfort

D., Gaillard E